Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OMI Stock Forecast 2025-2026
$7.38
Current Price
$543.19M
Market Cap
Buy 2
Hold 2
Sell 2
Wall St Analyst Ratings
Distance to OMI Price Targets
+76.2%
To High Target of $13.00
+28.7%
To Median Target of $9.50
-5.1%
To Low Target of $7.00
OMI Price Momentum
+5.3%
1 Week Change
+6.5%
1 Month Change
-60.4%
1 Year Change
-43.5%
Year-to-Date Change
-63.7%
From 52W High of $20.35
+21.6%
From 52W Low of $6.07
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Owens & Minor (OMI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on OMI and similar high-potential opportunities.
Latest OMI Stock Price Targets & Analyst Predictions
Based on our analysis of 15 Wall Street analysts, OMI has a neutral consensus with a median price target of $9.50 (ranging from $7.00 to $13.00). The overall analyst rating is Buy (6.7/10). Currently trading at $7.38, the median forecast implies a 28.7% upside. This outlook is supported by 2 Buy, 2 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Kevin Caliendo at UBS, projecting a 76.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OMI Analyst Ratings
2
Buy
2
Hold
2
Sell
OMI Price Target Range
Low
$7.00
Average
$9.50
High
$13.00
Current: $7.38
Latest OMI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OMI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 17, 2025 | Citigroup | Daniel Grosslight | Buy | Maintains | $11.00 |
| Mar 10, 2025 | JP Morgan | Michael Minchak | Underweight | Maintains | $10.00 |
| Mar 3, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $11.00 |
| Feb 25, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $10.00 |
| Feb 13, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $13.00 |
| Feb 4, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $14.00 |
| Nov 5, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $14.00 |
| Nov 5, 2024 | Barclays | Steven Valiquette | Equal-Weight | Maintains | $14.00 |
| Nov 5, 2024 | Citigroup | Daniel Grosslight | Buy | Maintains | $18.50 |
| Nov 5, 2024 | UBS | Kevin Caliendo | Buy | Maintains | $25.00 |
| Aug 21, 2024 | JP Morgan | Lisa Gill | Underweight | Maintains | $18.00 |
| Aug 5, 2024 | Barclays | Steven Valiquette | Equal-Weight | Maintains | $18.00 |
| Jul 19, 2024 | Citigroup | Daniel Grosslight | Buy | Upgrade | $19.00 |
| Jul 16, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $19.00 |
| Jun 25, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $20.00 |
| Jun 25, 2024 | B of A Securities | Underperform | Maintains | $16.00 | |
| May 6, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $24.00 |
| Apr 30, 2024 | Citigroup | Daniel Ford | Neutral | Maintains | $28.00 |
| Apr 10, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $28.00 |
| Feb 21, 2024 | Citigroup | Daniel Ford | Neutral | Maintains | $24.00 |
Owens & Minor Inc. (OMI) Competitors
The following stocks are similar to Owens & Minor based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Owens & Minor Inc. (OMI) Financial Data
Owens & Minor Inc. has a market capitalization of $543.19M with a P/E ratio of -1.6x. The company generates $10.72B in trailing twelve-month revenue with a -3.4% profit margin.
Revenue growth is +0.7% quarter-over-quarter, while maintaining an operating margin of +1.7% and return on equity of -49.9%.
Valuation Metrics
Market Cap
$543.19M
Enterprise Value
$2.76B
P/E Ratio
-1.6x
PEG Ratio
3.8x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
+0.7%
Gross Margin
+20.0%
Operating Margin
+1.7%
Net Margin
-3.4%
EPS Growth
+0.7%
Financial Health
Cash/Price Ratio
+10.5%
Current Ratio
1.1x
Debt/Equity
397.8x
ROE
-49.9%
ROA
+3.1%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Owens & Minor Inc. (OMI) Business Model
About Owens & Minor Inc.
What They Do
Distributes medical and surgical supplies globally.
Business Model
Owens & Minor generates revenue through the distribution of medical and surgical supplies to healthcare providers, including hospitals and health networks. Additionally, the company offers proprietary medical products, such as surgical kits and custom procedure trays, enhancing its revenue streams while supporting operational efficiencies in healthcare delivery.
Additional Information
Located in Mechanicsville, Virginia, Owens & Minor is essential in the healthcare supply chain, ensuring the timely delivery of critical supplies and contributing to the quality and accessibility of healthcare services.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
23,200
CEO
Mr. Edward A. Pesicka
Country
United States
IPO Year
1988
Website
www.owens-minor.comOwens & Minor Inc. (OMI) Latest News & Analysis
Latest News
Quick Summary
Owens & Minor, Inc. (NYSE:OMI) will hold its Q1 2025 earnings conference call on May 8, 2025, at 8:00 AM ET, featuring key company executives and analysts.
Why It Matters
Owens & Minor's Q1 2025 earnings call provides insights into financial performance, strategic direction, and market conditions, which can influence stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Owens & Minor, Inc. (NYSE: OMI) reported Q1 2025 results with mid-single digit top-line growth, driven by strong performance in Diabetes and Sleep Supplies, and mid-teen expansion in earnings.
Why It Matters
Owens & Minor's strong Q1 results indicate robust growth, particularly in key therapy categories, suggesting effective strategies that may enhance future profitability and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Owens & Minor Inc. (OMI) reported Q1 2025 adjusted EPS of 23 cents, exceeding the consensus estimate of 20 cents and rising from 19 cents in the previous year.
Why It Matters
Owens & Minor's Q1 2025 EPS beat expectations and showed year-over-year growth, indicating strong performance and potential for future gains, positively influencing investor sentiment.
Source: Benzinga
Market Sentiment:
Negative
Owens & Minor (OMI) Q1 Earnings Top Estimates
10 days ago
Quick Summary
Owens & Minor (OMI) reported quarterly earnings of $0.23 per share, surpassing the Zacks estimate of $0.20 and up from $0.19 per share year-over-year.
Why It Matters
Owens & Minor's earnings beat estimates and show year-over-year growth, indicating strong performance and potential for future gains, which may positively influence investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Owens & Minor, Inc. (NYSE: OMI) will release Q1 2025 financial results on May 8, 2025, before market open, followed by a conference call at 8:00 a.m. EDT. Access codes provided for participation.
Why It Matters
Owens & Minor's upcoming earnings release and conference call provide insights into the company's performance, affecting stock valuation and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Owens & Minor: A Painful Transformation
1 month ago
Quick Summary
Owens & Minor's aggressive acquisitions have resulted in high debt and mixed performance, causing skepticism about future prospects. A potential sale could reshape the business, but risks remain.
Why It Matters
Owens & Minor's high debt and mixed performance raise concerns about future growth. The shift to higher-margin activities is promising, but uncertainty over acquisitions and debt levels creates investment risk.
Source: Seeking Alpha
Market Sentiment:
Negative
Frequently Asked Questions About OMI Stock
What is Owens & Minor Inc.'s (OMI) stock forecast for 2025?
Based on our analysis of 15 Wall Street analysts, Owens & Minor Inc. (OMI) has a median price target of $9.50. The highest price target is $13.00 and the lowest is $7.00.
Is OMI stock a good investment in 2025?
According to current analyst ratings, OMI has 2 Buy ratings, 2 Hold ratings, and 2 Sell ratings. The stock is currently trading at $7.38. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OMI stock?
Wall Street analysts predict OMI stock could reach $9.50 in the next 12 months. This represents a 28.7% increase from the current price of $7.38. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Owens & Minor Inc.'s business model?
Owens & Minor generates revenue through the distribution of medical and surgical supplies to healthcare providers, including hospitals and health networks. Additionally, the company offers proprietary medical products, such as surgical kits and custom procedure trays, enhancing its revenue streams while supporting operational efficiencies in healthcare delivery.
What is the highest forecasted price for OMI Owens & Minor Inc.?
The highest price target for OMI is $13.00 from Kevin Caliendo at UBS, which represents a 76.2% increase from the current price of $7.38.
What is the lowest forecasted price for OMI Owens & Minor Inc.?
Price targets from Wall Street analysts for OMI are not currently available. The stock is trading at $7.38.
What is the overall OMI consensus from analysts for Owens & Minor Inc.?
The overall analyst consensus for OMI is neutral. Out of 15 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 2 as Sell, with a median price target of $9.50.
How accurate are OMI stock price projections?
Stock price projections, including those for Owens & Minor Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 9:15 AM UTC